Brace Pharma Capital

About The Fund

Brace Pharma Capital is a corporate venture capital firm with headquarters located at 121 Menachem Begin St, 17th Floor, Tel Aviv, 6701201, Israel, and a mailing address at 387 Technology Cir NW Suite 225, Atlanta GA 30313. They focus on equity investments within the Biotech, Medical Devices (& Hospital Services), and Life Science sectors, specifically targeting innovative, life-changing therapies for diseases that have high unmet medical need and insufficient treatment options, including the field of oncology. Their investment thesis centers on bringing innovative medicines to patients by supporting companies that are developing breakthrough therapeutic solutions. Brace Pharma Capital is involved throughout the investment lifecycle, assisting portfolio companies with their strategic direction and operational progression. They work to contribute to the development of transformative healthcare solutions by providing not just capital, but also by leveraging their expertise and network to foster the growth and success of their investments. Companies seeking consideration for investment are encouraged to contact them to explore potential partnerships. They also emphasize the importance of an experienced team and board of directors, highlighting that these key personnel play a crucial role in the firm's ability to identify and cultivate significant medical advancements. Brace Pharma Capital maintains an active presence on LinkedIn and encourages connections through the platform to expand their network and foster collaborative opportunities in the healthcare and life sciences ecosystem.